S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
S&P 500   4,027.81 (+1.42%)
DOW   32,717.60 (+1.00%)
QQQ   312.72 (+1.82%)
AAPL   160.77 (+1.98%)
MSFT   280.51 (+1.92%)
META   205.35 (+2.33%)
GOOGL   101.39 (+0.36%)
AMZN   100.25 (+3.10%)
TSLA   193.88 (+2.48%)
NVDA   269.84 (+2.17%)
NIO   9.83 (+6.85%)
BABA   99.92 (+1.54%)
AMD   96.09 (+1.62%)
T   19.00 (+1.50%)
F   12.05 (+3.88%)
MU   63.54 (+7.19%)
CGC   1.81 (+0.00%)
GE   94.06 (+0.99%)
DIS   96.87 (+2.16%)
AMC   5.00 (-2.91%)
PFE   40.25 (+0.65%)
PYPL   74.18 (+2.04%)
NFLX   332.03 (+2.63%)
NASDAQ:ALBO

Albireo Pharma - ALBO Institutional Ownership

$44.15
-0.10 (-0.23%)
(As of 03/2/2023)
Add
Compare
Today's Range
$43.99
$44.90
50-Day Range
$43.50
$44.95
52-Week Range
$16.02
$45.23
Volume
1.24 million shs
Average Volume
704,539 shs
Market Capitalization
$913.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$48.00

Institutional Ownership Changes (13F Filings) for Albireo Pharma (NASDAQ:ALBO)

Current
Institutional Ownership
Percentage
94.25%
Number of
Institutional Buyers
(last 12 months)
76
Total
Institutional Inflows
(last 12 months)
$122.64 M
Number of
Institutional Sellers
(last 12 months)
46
Total
Institutional Outflows
(last 12 months)
$78.34 M
Skip Chart & View Institutional Buying and Selling Data

ALBO Institutional Buying and Selling by Quarter

Get ALBO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Albireo Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Albireo Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2023Alliancebernstein L.P.25,200$0.55M0.0%+10.0%0.122%
2/15/2023Sphera Funds Management LTD.463,828$10.02M2.2%+29.2%2.241%
2/15/2023State of Wisconsin Investment Board15,802$0.34M0.0%-6.4%0.076%
2/15/2023Schonfeld Strategic Advisors LLC18,393$0.40M0.0%N/A0.089%
2/15/2023Tang Capital Management LLC411,968$8.90M1.3%-62.5%1.990%
2/15/2023Legal & General Group Plc6,990$0.15M0.0%+6.6%0.034%
2/15/2023Millennium Management LLC387,567$8.38M0.0%-24.2%1.872%
2/15/2023Morgan Stanley144,423$3.12M0.0%+17.4%0.698%
2/15/2023Endurant Capital Management LP217,209$4.69M1.9%+25.8%1.049%
2/15/2023Alps Advisors Inc.14,058$0.30M0.0%+30.8%0.068%
2/15/2023ArrowMark Colorado Holdings LLC786,664$17M0.2%-0.6%3.800%
2/14/2023Point72 Asset Management L.P.24,200$0.52M0.0%-69.0%0.117%
2/14/2023PDT Partners LLC23,587$0.51M0.1%N/A0.114%
2/13/2023Platinum Investment Management Ltd.306,834$6.63M0.3%+15.0%1.482%
2/13/2023Charles Schwab Investment Management Inc.49,296$1.07M0.0%+5.3%0.238%
2/13/2023Deutsche Bank AG8,278$0.18M0.0%-83.2%0.040%
2/13/2023Barclays PLC6,163$0.13M0.0%+207.7%0.030%
2/13/2023Renaissance Technologies LLC89,683$1.94M0.0%-35.8%0.433%
2/13/2023Geode Capital Management LLC333,211$7.20M0.0%+6.5%1.610%
2/13/2023JPMorgan Chase & Co.10,781$0.23M0.0%+13.5%0.052%
2/13/2023M&T Bank Corp14,779$0.32M0.0%-40.8%0.071%
2/10/2023Bank of America Corp DE12,342$0.27M0.0%+98.0%0.060%
2/10/2023American International Group Inc.8,613$0.19M0.0%+5.4%0.042%
2/10/2023GW&K Investment Management LLC634,701$13.72M0.1%-1.4%3.066%
2/10/2023Connor Clark & Lunn Investment Management Ltd.9,724$0.21M0.0%-3.3%0.047%
2/10/2023Franklin Resources Inc.925,070$19.99M0.0%0.0%4.469%
2/10/2023Cheyne Capital Management UK LLP13,364$0.29M0.5%N/A0.065%
2/9/2023Dimensional Fund Advisors LP269,731$5.83M0.0%+2.0%1.303%
2/9/2023MAI Capital Management265,364$5.74M0.1%-34.8%1.282%
2/9/2023Saturn V Capital Management LLC341,827$6.87M5.7%N/A1.651%
2/8/2023UBS Group AG6,164$0.13M0.0%+705.8%0.030%
2/8/2023Fiera Capital Corp126,109$2.73M0.0%-1.9%0.609%
2/8/2023Swiss National Bank42,600$0.92M0.0%+4.2%0.206%
2/8/2023Russell Investments Group Ltd.21,662$0.47M0.0%+2,691.5%0.105%
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank 5,713$0.12M0.0%+16.6%0.028%
2/1/2023International Biotechnology Trust PLC38,000$0.82M0.3%+136.1%0.184%
1/27/2023Rice Hall James & Associates LLC513,525$11.10M0.6%+1.9%2.481%
1/20/2023Chicago Capital LLC1,362,484$29.44M1.6%+21.7%6.582%
12/8/2022Bank of New York Mellon Corp85,722$1.66M0.0%-1.6%0.414%
11/28/2022Birchview Capital LP117,000$2.27M1.5%+3.5%0.565%
11/17/2022M&T Bank Corp24,962$0.48M0.0%+17.0%0.121%
11/16/2022Jane Street Group LLC61,652$1.19M0.0%+152.7%0.298%
11/16/2022BNP Paribas Arbitrage SNC13,840$0.27M0.0%+112.9%0.067%
11/15/2022State Street Corp350,544$6.79M0.0%-75.4%1.693%
11/15/2022Tang Capital Management LLC1,099,516$21.29M2.6%+57.1%5.311%
11/15/2022Two Sigma Advisers LP11,900$0.23M0.0%-54.2%0.057%
11/15/2022Vanguard Group Inc.917,480$17.76M0.0%-7.7%4.432%
11/15/2022Platinum Investment Management Ltd.266,917$5.17M0.2%+16.6%1.289%
11/15/2022Prosight Management LP491,244$9.51M5.1%+5.0%2.373%
11/15/2022Endurant Capital Management LP172,621$3.34M1.1%+356.2%0.834%
11/15/2022Federated Hermes Inc.2,258,124$43.72M0.1%+0.1%10.909%
11/15/2022Bank of New York Mellon Corp85,722$1.66M0.0%-1.6%0.414%
11/15/2022BlackRock Inc.1,215,406$23.53M0.0%+0.2%5.872%
11/15/2022Brandywine Global Investment Management LLC42,168$0.82M0.0%-3.7%0.204%
11/14/2022Point72 Hong Kong Ltd3,304$64K0.0%N/A0.016%
11/14/2022Point72 Asset Management L.P.78,100$1.51M0.0%N/A0.377%
11/14/2022Cubist Systematic Strategies LLC3,710$72K0.0%N/A0.018%
11/14/2022Renaissance Technologies LLC139,683$2.70M0.0%+616.3%0.675%
11/14/2022Ergoteles LLC19,943$0.39M0.0%N/A0.096%
11/14/2022Nuveen Asset Management LLC93,063$1.80M0.0%+149.6%0.450%
11/14/2022Psagot Value Holdings Ltd. Israel6,800$0.13M0.0%N/A0.033%
11/10/2022Quadrant Capital Group LLC1,709$33K0.0%+4,397.4%0.009%
11/10/2022Connor Clark & Lunn Investment Management Ltd.10,061$0.20M0.0%N/A0.051%
11/10/2022ExodusPoint Capital Management LP35,874$0.70M0.0%-32.2%0.183%
11/10/2022Dimensional Fund Advisors LP264,536$5.12M0.0%-32.0%1.349%
11/10/2022Tower Research Capital LLC TRC16,732$0.32M0.0%+560.6%0.085%
11/8/2022Decheng Capital Management III Cayman LLC623,342$12.07M4.4%+20.3%3.179%
11/8/2022International Biotechnology Trust PLC16,093$0.31M0.1%N/A0.082%
11/8/2022New York State Common Retirement Fund11,764$0.23M0.0%-57.5%0.060%
11/7/2022Birchview Capital LP117,000$2.27M1.6%+3.5%0.597%
11/7/2022Quantbot Technologies LP6,200$0.12M0.0%+4,175.9%0.032%
11/4/2022Prudential Financial Inc.25,700$0.50M0.0%-61.9%0.131%
11/3/2022Fiera Capital Corp128,486$1.64M0.0%+140.6%0.655%
11/3/2022Barclays PLC2,003$39K0.0%+131.6%0.010%
11/2/2022DekaBank Deutsche Girozentrale45,000$0.82M0.0%+28.6%0.229%
11/1/2022Rice Hall James & Associates LLC504,138$9.76M0.6%+8.2%2.570%
10/31/2022SG Americas Securities LLC8,583$0.17M0.0%-21.0%0.044%
10/26/2022Allspring Global Investments Holdings LLC1,640$31K0.0%+169.3%0.008%
10/14/2022Chicago Capital LLC1,119,774$21.68M1.3%-17.1%5.709%
9/16/2022Federated Hermes Inc.2,255,124$44.79M0.1%-4.4%11.498%
8/22/2022ExodusPoint Capital Management LP52,905$1.05M0.0%N/A0.270%
8/18/2022Goldman Sachs Group Inc.76,689$1.52M0.0%+77.0%0.396%
8/16/2022Prudential Financial Inc.67,500$1.34M0.0%-33.0%0.349%
8/16/2022CSS LLC IL12,143$0.24M0.0%-36.4%0.063%
8/16/2022Caption Management LLC4,300$85K0.0%-95.5%0.022%
8/15/2022State Street Corp1,424,343$28.29M0.0%+56.7%7.356%
8/15/2022Millennium Management LLC32,454$0.65M0.0%-46.7%0.168%
8/15/2022Sio Capital Management LLC58,556$1.16M0.4%-59.5%0.302%
8/13/2022Renaissance Technologies LLC19,500$0.39M0.0%+103.1%0.101%
8/13/2022Prosight Management LP467,795$9.29M7.3%-2.5%2.416%
8/12/2022Northern Trust Corp181,432$3.60M0.0%-1.7%0.937%
8/12/2022Ensign Peak Advisors Inc6,640$0.13M0.0%+22.3%0.034%
8/12/2022Credit Suisse AG11,335$0.23M0.0%+4.5%0.059%
8/12/2022Rafferty Asset Management LLC57,758$1.15M0.0%+15.3%0.298%
8/12/2022BNP Paribas Arbitrage SA6,502$0.13M0.0%+85.5%0.034%
8/12/2022Brandywine Global Investment Management LLC43,800$0.87M0.0%-12.9%0.226%
8/12/2022Franklin Resources Inc.872,898$17.34M0.0%+82.5%4.508%
8/12/2022Rhumbline Advisers19,873$0.40M0.0%+10.6%0.103%
8/11/2022Deutsche Bank AG50,432$1M0.0%+426.0%0.260%
8/11/2022Platinum Investment Management Ltd.228,821$4.54M0.2%-14.2%1.182%
(Data available from 1/1/2016 forward)













ALBO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ALBO shares?

During the previous two years, 113 institutional investors and hedge funds held shares of Albireo Pharma. The most heavily invested institutionals were Federated Hermes Inc. ($43.72M), Chicago Capital LLC ($29.44M), BlackRock Inc. ($23.53M), Franklin Resources Inc. ($19.99M), Vanguard Group Inc. ($17.76M), ArrowMark Colorado Holdings LLC ($17M), and GW&K Investment Management LLC ($13.72M).Learn more on ALBO's institutional investors.

What percentage of Albireo Pharma stock is owned by institutional investors?

94.25% of Albireo Pharma stock is owned by institutional investors. Learn more on ALBO's institutional investor holdings.

Which institutional investors have been buying Albireo Pharma stock?

Of the 99 institutional investors that purchased Albireo Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Chicago Capital LLC ($0.98M), Decheng Capital Management III Cayman LLC ($0.62M), State Street Corp ($0.52M), Nicholas Investment Partners LP ($0.44M), Franklin Resources Inc. ($0.42M), Tang Capital Management LLC ($0.40M), and Privium Fund Management UK Ltd ($0.38M).

How much institutional buying is happening at Albireo Pharma?

Institutional investors have bought a total of 7,191,493 shares in the last 24 months. This purchase volume represents approximately $177.49M in transactions.

Which Albireo Pharma major shareholders have been selling company stock?

Of the 62 institutional investors that sold Albireo Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($1.31M), Tang Capital Management LLC ($0.69M), Marshall Wace LLP ($0.48M), Chicago Capital LLC ($0.23M), Goldman Sachs Group Inc. ($0.22M), Dimensional Fund Advisors LP ($0.20M), and Millennium Management LLC ($0.19M).

How much institutional selling is happening at Albireo Pharma?

Institutional investors have sold a total of 5,292,741 shares in the last 24 months. This volume of shares sold represents approximately $133.80M in transactions.

This page (NASDAQ:ALBO) was last updated on 3/29/2023 by MarketBeat.com Staff